| Application no. and date | 09011761.5 (espacenet) (Federated) (European Patent Register), 19990528 | | Patent/reg. no. and date | DK/EP 2143420, 20140625 | | Publication date | 20100113 | | Priority no. and date | US 87804, 19980601 | | EP pub. no. and date |
EP 2143420 20100113 | | Effective date | | | Applicant/owner | The Mount Sinai School of Medicine of New York
University, One Gustave L. Levy Place,
Box 1675
New York, NY 10029, US | | Applicant ref. no. | AMICUS AT-P0100-EP-DIV | | Inventor | Ishi, Satoshi, 4-4-20, Omichi-machi
Grace Court Omichi 302
Oita-shi 870-0822, JP,
Fan, Jian-Qiang, 326 Prospect Avenue
3th Floor
Hackensack
NJ 07601, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/445 (2006.01) , A61K 31/7008 (2006.01) , A61K 9/00 (2006.01) , C12N 9/24 (2006.01) | | Title | Formulering, der omfatter mutant(er) af lysosomal alfa-galactosidase A, til behandling af Fabrys sygdom | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
